Evidence map›Paper›PMID 39918320›Full record

ArticleMicrobiology spectrum2025

Mecillinam activity against multidrug-resistant

Aleksandra Stefanovic, Leah Gowland, Gordon Ritchie, Colin Lee, Sam Chorlton, Nancy Matic, Victor Leung, Michael Payne, Christopher F Lowe, Marc G Romney

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbiology spectrum, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Aleksandra StefanovicDivision of Medical Microbiology and Virology, St. Paul's Hospital, Providence Health Care, Vancouver, British Columbia, Canada.ORCID 0000-0001-9299-2040
Leah GowlandDivision of Medical Microbiology and Virology, St. Paul's Hospital, Providence Health Care, Vancouver, British Columbia, Canada.
Gordon RitchieDivision of Medical Microbiology and Virology, St. Paul's Hospital, Providence Health Care, Vancouver, British Columbia, Canada.
Colin LeeDepartment of Pharmacy, Providence Health Care, Vancouver, British Columbia, Canada.
Sam ChorltonBugSeq Bioinformatics Inc., Vancouver, British Columbia, Canada.
Nancy MaticDivision of Medical Microbiology and Virology, St. Paul's Hospital, Providence Health Care, Vancouver, British Columbia, Canada.ORCID 0000-0002-4158-6955
Victor LeungDivision of Medical Microbiology and Virology, St. Paul's Hospital, Providence Health Care, Vancouver, British Columbia, Canada.
Michael PayneDivision of Medical Microbiology and Virology, St. Paul's Hospital, Providence Health Care, Vancouver, British Columbia, Canada.
Christopher F LoweDivision of Medical Microbiology and Virology, St. Paul's Hospital, Providence Health Care, Vancouver, British Columbia, Canada.ORCID 0000-0001-9320-4499
Marc G RomneyDivision of Medical Microbiology and Virology, St. Paul's Hospital, Providence Health Care, Vancouver, British Columbia, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We performed phenotypic susceptibility testing and whole-genome sequencing to investigate IMPORTANCE: Rapidly emerging resistance in

Indexed as

AmdinocillinAnti-Bacterial AgentsDrug Resistance, Multiple, BacterialShigella flexneriShigella sonneiDysentery, BacillaryHumansMicrobial Sensitivity TestsWhole Genome SequencingAmdinocillinAnti-Bacterial Agentsantimicrobial resistancediarrheamecillinammultidrug resistancepivmecillinamShigella

Identifiers

PMID39918320
PMCPMC11878017

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.